{"count":43797,"next":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=25440&ordering=-accession","previous":"https://cinder.proteo.info/api/ms_vocab/?format=json&limit=20&offset=25400&ordering=-accession","results":[{"accession":"CLO:0017588","name":"GM16528 cell","definition":"[' HEMOGLOBIN--BETA LOCUS; HBB']","term_type":"cell line"},{"accession":"CLO:0017587","name":"GM16523 cell","definition":"[' ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM']","term_type":"cell line"},{"accession":"CLO:0017586","name":"GM16524 cell","definition":"[' ADRENOLEUKODYSTROPHY, AUTOSOMAL NEONATAL FORM']","term_type":"cell line"},{"accession":"CLO:0017585","name":"ND01345 cell","definition":"[\" PARKINSON'S DISEASE\"]","term_type":"cell line"},{"accession":"CLO:0017584","name":"GM16532 cell","definition":"[' CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A MELANOMA, CUTANEOUS MALIGNANT, 2; CMM2']","term_type":"cell line"},{"accession":"CLO:0017583","name":"GM16533 cell","definition":"[' CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A MELANOMA, CUTANEOUS MALIGNANT, 2; CMM2']","term_type":"cell line"},{"accession":"CLO:0017582","name":"GM16529 cell","definition":"[' HEMOGLOBIN--BETA LOCUS; HBB']","term_type":"cell line"},{"accession":"CLO:0017581","name":"GM16530 cell","definition":"[' ATP SYNTHASE 6; MTATP6']","term_type":"cell line"},{"accession":"CLO:0017580","name":"GM16534 cell","definition":"[' MELANOMA, CUTANEOUS MALIGNANT, 2; CMM2 CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A']","term_type":"cell line"},{"accession":"CLO:0017579","name":"GM16535 cell","definition":"[' MELANOMA, CUTANEOUS MALIGNANT, 2; CMM2 CYCLIN-DEPENDENT KINASE INHIBITOR 2A; CDKN2A']","term_type":"cell line"},{"accession":"CLO:0017578","name":"ND01325 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0017577","name":"ND01324 cell","definition":"[' EPILEPSY']","term_type":"cell line"},{"accession":"CLO:0017576","name":"ND01323 cell","definition":"[' SPOUSAL CONTROL NEUROLOGICALLY NORMAL CAUCASIAN CONTROL PANEL']","term_type":"cell line"},{"accession":"CLO:0017575","name":"ND01322 cell","definition":"[\" YOUNG ONSET PARKINSON'S DISEASE; AFFECTED INDIVIDUALS PARKINSON'S DISEASE\"]","term_type":"cell line"},{"accession":"CLO:0017574","name":"ND07274 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0017573","name":"ND01336 cell","definition":"[' POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"},{"accession":"CLO:0017572","name":"ND01334 cell","definition":"[\" PARKINSON'S DISEASE YOUNG ONSET PARKINSON'S DISEASE; AFFECTED INDIVIDUALS\"]","term_type":"cell line"},{"accession":"CLO:0017571","name":"ND07273 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"},{"accession":"CLO:0017570","name":"ND01333 cell","definition":"[' ESSENTIAL TREMOR-MOVEMENT DISORDER POPULATION/CONVENIENCE CONTROL']","term_type":"cell line"},{"accession":"CLO:0017569","name":"ND01326 cell","definition":"[' ASYMPTOMATIC AND GENETICALLY RELATED TO AN AFFECTED INDIVIDUAL']","term_type":"cell line"}]}